Stephen Stahl

Title(s)Adjunct Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    HUMAN 5HT RECEPTOR REGULATION BY ANTIDEPRESSANTS
    NIH R01MH045787Sep 1, 1991 - Jan 31, 1995
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Response to the Letter to the Editor "Psychiatry's undeclared identity crisis in a changing world" by Richard Skaff. CNS Spectr. 2021 May 31; 1-2. Marazziti D, Stahl SM. PMID: 34053472.
      View in: PubMed   Mentions:    Fields:    
    2. REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study. Front Pharmacol. 2021; 12:671859. De Martin S, Gabbia D, Folli F, Bifari F, Fiorina P, Ferri N, Stahl S, Inturrisi CE, Pappagallo M, Traversa S, Manfredi PL. PMID: 33995104.
      View in: PubMed   Mentions:
    3. Healthcare Provider Perspectives on Bipolar I Disorder Screening and the Rapid Mood Screener (RMS), a Pragmatic, New Tool. CNS Spectr. 2021 Apr; 26(2):181-183. Thase ME, Stahl SM, McIntyre RS, Matthews-Hayes T, Patel M, Harrington A, Maletic V, Jackson WC, Vieta E. PMID: 33928881.
      View in: PubMed   Mentions:    Fields:    
    4. Early response to trazodone once-a-day in major depressive disorder: review of the clinical data and putative mechanism for faster onset of action. CNS Spectr. 2021 Jun; 26(3):232-242. Albert U, Lamba P, Stahl SM. PMID: 33731232.
      View in: PubMed   Mentions:    Fields:    
    5. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. Am J Psychiatry. 2021 May 01; 178(5):383-399. McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA, Stahl S. PMID: 33726522.
      View in: PubMed   Mentions: 2     Fields:    
    6. How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice. Acta Psychiatr Scand. 2021 02; 143(2):172-180. Stahl SM, Sy S, Maguire GA. PMID: 33306204.
      View in: PubMed   Mentions:    Fields:    
    7. The Cal-DSH diversion guidelines. CNS Spectr. 2020 10; 25(5):701-713. Cummings MA, Scott C, Arguello JC, Arias AW, Breth AM, Delgado D, Harvey PD, Meyer JM, O'Day J, Pollock M, Proctor G, Rector T, Rose B, Schwartz E, Thordarson H, Warburton K, Stahl SM. PMID: 33111661.
      View in: PubMed   Mentions:    Fields:    
    8. Dementia-related psychosis and the potential role for pimavanserin. CNS Spectr. 2020 Aug 19; 1-9. Cummings JL, Devanand DP, Stahl SM. PMID: 32811586.
      View in: PubMed   Mentions:    Fields:    
    9. A social history of serious mental illness. CNS Spectr. 2020 10; 25(5):584-592. Daugherty B, Warburton K, Stahl SM. PMID: 32393403.
      View in: PubMed   Mentions:    Fields:    
    10. The relevance of COVID-19 pandemic to psychiatry. World Psychiatry. 2020 Jun; 19(2):261. Marazziti D, Stahl SM. PMID: 32394565.
      View in: PubMed   Mentions:
    11. New Medications for Neuropsychiatric Disorders. Psychiatr Clin North Am. 2020 06; 43(2):399-413. Reddy HM, Poole JS, Maguire GA, Stahl SM. PMID: 32439029.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Breaking down long-term chronic aggression within a forensic hospital system. CNS Spectr. 2020 04; 25(2):216-222. Rose B, Broderick C, Delgado D, Kornbluh R, Stahl SM. PMID: 32331057.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Balancing the pendulum: rethinking the role of institutionalization in the treatment of serious mental illness. CNS Spectr. 2020 04; 25(2):115-118. Warburton K, Stahl SM. PMID: 32331093.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Precision and personalized assessment, diagnosis and treatment in psychiatry. CNS Spectr. 2020 Mar 31; 1-7. Fountoulakis KN, Stahl SM. PMID: 32228728.
      View in: PubMed   Mentions:    Fields:    
    15. Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data. Ther Adv Psychopharmacol. 2020; 10:2045125320905752. Stahl SM, Laredo S, Morrissette DA. PMID: 32110377.
      View in: PubMed   Mentions:
    16. Novel challenges to psychiatry from a changing world. CNS Spectr. 2021 02; 26(1):3-4. Marazziti D, Stahl SM. PMID: 31983351.
      View in: PubMed   Mentions:    Fields:    
    17. A survey of national trends in psychiatric patients found incompetent to stand trial: reasons for the reinstitutionalization of people with serious mental illness in the United States. CNS Spectr. 2020 04; 25(2):245-251. Warburton K, McDermott BE, Gale A, Stahl SM. PMID: 31916928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Economics of decriminalizing mental illness: when doing the right thing costs less. CNS Spectr. 2020 10; 25(5):566-570. Delgado D, Breth A, Hill S, Warburton K, Stahl SM. PMID: 31910935.
      View in: PubMed   Mentions:    Fields:    
    19. Pharmacologic Treatment of Mixed States. Psychiatr Clin North Am. 2020 03; 43(1):167-186. Pompili M, Vazquez GH, Forte A, Morrissette DA, Stahl SM. PMID: 32008683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Dextromethorphan/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity-Addendum. CNS Spectr. 2020 12; 25(6):803. Stahl SM. PMID: 31771670.
      View in: PubMed   Mentions:    Fields:    
    21. Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies. CNS Spectr. 2020 08; 25(4):502-510. McIntyre RS, Suppes T, Earley W, Patel M, Stahl SM. PMID: 31576791.
      View in: PubMed   Mentions: 2     Fields:    
    22. Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity. CNS Spectr. 2019 10; 24(5):461-466. Stahl SM. PMID: 31566163.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    23. Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. CNS Spectr. 2019 10; 24(5):574-575. Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM. PMID: 31182180.
      View in: PubMed   Mentions:    Fields:    
    24. Mixed mood states: Baffled, bewildered, befuddled and bemused. Bipolar Disord. 2019 09; 21(6):560-561. Stahl SM, Morrissette DA. PMID: 31025466.
      View in: PubMed   Mentions: 1     Fields:    
    25. Psychopharmacology and ethnicity: A comparative study on Senegalese and Italian men. World J Biol Psychiatry. 2020 04; 21(4):300-307. Marazziti D, Stahl SM, Simoncini M, Baroni S, Mucci F, Palego L, Betti L, Massimetti G, Giannaccini G, Dell'Osso L. PMID: 31012797.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Placebo response rate is ruining drug development in psychiatry: why is this happening and what can we do about it? Acta Psychiatr Scand. 2019 02; 139(2):105-107. Stahl SM, Greenberg GD. PMID: 30680707.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Expert Consensus on Screening and Assessment of Cognition in Psychiatry. CNS Spectr. 2019 02; 24(1):154-162. McIntyre RS, Anderson N, Baune BT, Brietzke E, Burdick K, Fossati P, Gorwood P, Harmer C, Harrison J, Harvey P, Mansur RB, Medalia A, Miskowiak K, Ramey T, Rong C, Rosenblat JD, Young A, Stahl SM. PMID: 30642417.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. CNS Spectr. 2018 12; 23(6):402-413. Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM. PMID: 30588905.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis. CNS Spectr. 2018 10; 23(5):291-297. Stahl SM. PMID: 30382934.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other? CNS Spectr. 2018 08; 23(4):239-247. Stahl SM. PMID: 30160230.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    31. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectr. 2018 06; 23(3):187-191. Stahl SM. PMID: 29954475.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    32. Antagonist treatment is just as effective as replacement therapy for opioid addiction but neither is used often enough. CNS Spectr. 2018 04; 23(2):113-116. Stahl SM. PMID: 29676241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Serotonin and Love: Supporting Evidence From a Patient Suffering From Obsessive-Compulsive Disorder. J Clin Psychopharmacol. 2018 02; 38(1):99-101. Marazziti D, Stahl SM. PMID: 29189409.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Mixed-up about how to diagnose and treat mixed features in major depressive episodes - CORRIGENDUM. CNS Spectr. 2018 04; 23(2):185. Stahl SM. PMID: 29353558.
      View in: PubMed   Mentions:    Fields:    
    35. Deuterium Tetrabenazine for Tardive Dyskinesia. Clin Schizophr Relat Psychoses. 2018 Jan; 11(4):214-220. Cummings MA, Proctor GJ, Stahl SM. PMID: 29341821.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less "go" and more "stop" from the motor striatum for robust therapeutic effects. CNS Spectr. 2018 02; 23(1):1-6. Stahl SM. PMID: 29249207.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    37. Neuronal traffic signals in tardive dyskinesia: not enough "stop" in the motor striatum. CNS Spectr. 2017 12; 22(6):427-434. Stahl SM. PMID: 29205123.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. Conditions of life and death of psychiatric patients in France during World War II: euthanasia or collateral casualties? CNS Spectr. 2018 04; 23(2):170-175. Lemoine P, Stahl SM. PMID: 29081316.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes. CNS Spectr. 2017 10; 22(5):375-384. Stahl SM. PMID: 28965530.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    40. Does a "whiff" of mania in a major depressive episode shift treatment from a classical antidepressant to an atypical/second-generation antipsychotic? Bipolar Disord. 2017 11; 19(7):595-596. Stahl SM, Morrissette DA. PMID: 28895270.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Evil, terrorism, and psychiatry. CNS Spectr. 2018 04; 23(2):117-118. Marazziti D, Stahl SM. PMID: 28870267.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors. CNS Spectr. 2017 Aug; 22(4):305-311. Stahl SM. PMID: 28758887.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    43. Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing. BJPsych Bull. 2017 Jun; 41(3):164-168. Moore BA, Morrissette DA, Meyer JM, Stahl SM. PMID: 28584654.
      View in: PubMed   Mentions:
    44. Flibanserin - the female Viagra? Int J Psychiatry Clin Pract. 2017 Nov; 21(4):259-265. Shapiro D, Stevens D, Stahl SM. PMID: 28434386.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Does treating hearing loss prevent or slow the progress of dementia? Hearing is not all in the ears, but who's listening? CNS Spectr. 2017 Jun; 22(3):247-250. Stahl SM. PMID: 28376938.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design. J Pain Res. 2017; 10:635-641. Keppel Hesselink JM, Kopsky DJ, Stahl SM. PMID: 28360532.
      View in: PubMed   Mentions:
    47. Mixed-up about how to diagnose and treat mixed features in major depressive episodes. CNS Spectr. 2017 Apr; 22(2):111-115. Stahl SM. PMID: 28271818.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Guidelines for the recognition and management of mixed depression. CNS Spectr. 2017 Apr; 22(2):203-219. Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, Thase ME, Vieta E, Young A, Zimmerman M, McIntyre RS. PMID: 28421980.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    49. Kick-Off Editorial for 2017: CNS Spectrums Is on the Move. CNS Spectr. 2017 Feb; 22(1):5-6. Stahl SM. PMID: 28168944.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Psychiatric Pharmacogenomics: How to Integrate into Clinical Practice. CNS Spectr. 2017 Feb; 22(1):1-4. Stahl SM. PMID: 28168945.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Inverse agonists - What do they mean for psychiatry? Eur Neuropsychopharmacol. 2017 01; 27(1):87-90. Nutt D, Stahl S, Blier P, Drago F, Zohar J, Wilson S. PMID: 27955830.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    52. Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression? CNS Spectr. 2016 Dec; 21(6):419-423. Stahl SM. PMID: 27855728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    53. Psychopharmacology of Persistent Violence and Aggression. Psychiatr Clin North Am. 2016 12; 39(4):541-556. Meyer JM, Cummings MA, Proctor G, Stahl SM. PMID: 27836150.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clin Proc. 2017 Jan; 92(1):114-128. Goldstein I, Kim NN, Clayton AH, DeRogatis LR, Giraldi A, Parish SJ, Pfaus J, Simon JA, Kingsberg SA, Meston C, Stahl SM, Wallen K, Worsley R. PMID: 27916394.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    55. Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction. Case Rep Psychiatry. 2016; 2016:5606098. Meyer JM, Proctor G, Cummings MA, Dardashti LJ, Stahl SM. PMID: 27872784.
      View in: PubMed   Mentions:
    56. Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome. CNS Spectr. 2016 Oct; 21(5):355-359. Stahl SM. PMID: 27686027.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    57. Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors. CNS Spectr. 2016 Aug; 21(4):271-5. Stahl SM. PMID: 27503570.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. Mechanism of action of suvorexant. CNS Spectr. 2016 Jun; 21(3):215-8. Stahl SM. PMID: 27322687.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Using neuroscience for naming psychotropic drugs. CNS Spectr. 2016 Jun; 21(3):219-20. Stahl SM. PMID: 27322688.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Mechanism of action of cariprazine. CNS Spectr. 2016 Apr; 21(2):123-7. Stahl SM. PMID: 26956157.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    61. Mechanism of action of brexpiprazole: comparison with aripiprazole. CNS Spectr. 2016 Feb; 21(1):1-6. Stahl SM. PMID: 26899451.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    62. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. Eur Neuropsychopharmacol. 2015 Dec; 25(12):2318-25. Zohar J, Stahl S, Moller HJ, Blier P, Kupfer D, Yamawaki S, Uchida H, Spedding M, Goodwin GM, Nutt D. PMID: 26527055.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    63. Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability. Am J Med. 2015 Sep; 128(9 Suppl):S1-S15. Culpepper L, Muskin PR, Stahl SM. PMID: 26337210.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    64. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine. CNS Spectr. 2015 Oct; 20(5):455-9. Stahl SM. PMID: 26122791.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    65. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): modifying serotonin's downstream effects on glutamate and GABA (gamma amino butyric acid) release. CNS Spectr. 2015 Aug; 20(4):331-6. Stahl SM. PMID: 26062900.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    66. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters. CNS Spectr. 2015 Dec; 20(6):515-9. Stahl SM. PMID: 26062986.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    67. Treat the treatable: a comprehensive and optimistic approach to treating psychiatric violence. CNS Spectr. 2015 Jun; 20(3):170-1. Warburton KD, Stahl SM. PMID: 25997604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Is impulsive violence an addiction? The Habit Hypothesis. CNS Spectr. 2015 Jun; 20(3):165-9. Stahl SM. PMID: 25912294.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors). CNS Spectr. 2015 Apr; 20(2):93-7. Stahl SM. PMID: 25831967.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    70. Forensic focused treatment planning: a new standard for forensic mental health systems. CNS Spectr. 2015 Jun; 20(3):250-3. Schaufenbil RJ, Kornbluh R, Stahl SM, Warburton KD. PMID: 25801440.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Modulating the serotonin system in the treatment of major depressive disorder-ERRATUM. CNS Spectr. 2015 Aug; 20(4):452-3. Morrissette DA, Stahl SM. PMID: 25731078.
      View in: PubMed   Mentions:    Fields:    
    72. Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder. CNS Spectr. 2015 Feb; 20(1):1-6. Stahl SM. PMID: 25659981.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    73. Modulating the serotonin system in the treatment of major depressive disorder. CNS Spectr. 2014 Dec; 19 Suppl 1:57-67; quiz 54-7, 68. Morrissette DA, Stahl SM. PMID: 25544378.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    74. Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients. CNS Spectr. 2014 Dec; 19(6):475-8. Stahl SM. PMID: 25422900.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits. CNS Spectr. 2014 Oct; 19(5):357-65. Stahl SM. PMID: 25296964.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    76. California State Hospital Violence Assessment and Treatment (Cal-VAT) guideline. CNS Spectr. 2014 Oct; 19(5):449-65. Stahl SM, Morrissette DA, Cummings M, Azizian A, Bader S, Broderick C, Dardashti L, Delgado D, Meyer J, O'Day J, Proctor G, Rose B, Schur M, Schwartz E, Velasquez S, Warburton K. PMID: 27358935.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. California State Hospital Violence Assessment and Treatment (Cal-VAT) guidelines. CNS Spectr. 2014 Oct; 19(5):449-465. Stahl SM, Morrissette DA, Cummings M, Azizian A, Bader S, Broderick C, Dardashti L, Delgado D, Meyer J, O'Day J, Proctor G, Rose B, Schur M, Schwartz E, Velasquez S, Warburton K. PMID: 28480838.
      View in: PubMed   Mentions: 3     Fields:    
    78. Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy. CNS Spectr. 2014 Oct; 19(5):439-48. Morrissette DA, Stahl SM. PMID: 25119976.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    79. Clozapine: is now the time for more clinicians to adopt this orphan? CNS Spectr. 2014 Aug; 19(4):279-81. Stahl SM. PMID: 25267329.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial. J Clin Psychiatry. 2014 Aug; 75(8):855-63. Papakostas GI, Shelton RC, Zajecka JM, Bottiglieri T, Roffman J, Cassiello C, Stahl SM, Fava M. PMID: 24813065.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    81. Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties. CNS Spectr. 2014 Jun; 19(3):207-12. Stahl SM. PMID: 24901504.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    82. Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor. CNS Spectr. 2014 Apr; 19(2):105-9. Stahl SM. PMID: 24673885.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    83. Long-acting injectable antipsychotics: shall the last be first? CNS Spectr. 2014 Feb; 19(1):3-5. Stahl SM. PMID: 24512639.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    84. Role of a1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms. CNS Spectr. 2013 Dec; 18(6):285-8. Stahl SM. PMID: 24300463.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    85. Novel agents in development for the treatment of depression. CNS Spectr. 2013 Dec; 18 Suppl 1:37-40; quiz 41. Grady MM, Stahl SM. PMID: 24252548.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Pharmacotherapy of cognitive deficits in schizophrenia. CNS Spectr. 2014 Apr; 19(2):142-56. Opler LA, Medalia A, Opler MG, Stahl SM. PMID: 24229725.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    87. Mechanism of action of dextromethorphan/quinidine:comparison with ketamine. CNS Spectr. 2013 Oct; 18(5):225-7. Stahl SM. PMID: 24050154.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol. 2014 Jul; 24(7):1005-14. Zohar J, Nutt DJ, Kupfer DJ, Moller HJ, Yamawaki S, Spedding M, Stahl SM. PMID: 24630385.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    89. Controversies in treating bipolar depression. CNS Spectr. 2013 Aug; 18(4):175-6. Stahl SM. PMID: 23866090.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. Mechanism of action of ketamine. CNS Spectr. 2013 Aug; 18(4):171-4. Stahl SM. PMID: 23866089.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    91. Translating from neuroscience to psychiatry (and back translating from psychiatry to neuroscience). Acta Psychiatr Scand. 2013 Aug; 128(2):103-4. Acta Psychiatrica Scandinavica , Stahl SM. PMID: 23829230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. “Meta-guidelines” for the management of patients with schizophrenia. CNS Spectr. 2013 Jun; 18(3):150-162. Stahl SM, Morrissette DA, Citrome L, Saklad SR, Cummings MA, Meyer JM, O'Day JA, Dardashti LJ, Warburton KD. PMID: 23591126.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    93. Classifying psychotropic drugs by mode of action and not by target disorder. CNS Spectr. 2013 Jun; 18(3):113-7. Stahl SM. PMID: 23706705.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    94. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities? Trends Pharmacol Sci. 2013 Jun; 34(6):332-9. Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A. PMID: 23642658.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    95. Serotonergic drugs for depression and beyond. Curr Drug Targets. 2013 May 01; 14(5):578-85. Stahl SM, Lee-Zimmerman C, Cartwright S, Morrissette DA. PMID: 23531115.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    96. The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses. CNS Spectr. 2013 Apr; 18(2):65-8. Stahl SM. PMID: 23691552.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study. J Clin Psychiatry. 2013 May; 74(5):507-15. Stahl SM, Cucchiaro J, Simonelli D, Hsu J, Pikalov A, Loebel A. PMID: 23541189.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    98. Emerging guidelines for the use of antipsychotic polypharmacy. Rev Psiquiatr Salud Ment. 2013 Jul-Sep; 6(3):97-100. Stahl SM. PMID: 23485567.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    99. Off-label prescribing: best practice or malpractice? CNS Spectr. 2013 Feb; 18(1):1-4. Stahl SM. PMID: 23593650.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. The tyranny of the majority and the interchangeability of drugs. Acta Psychiatr Scand. 2013 Jan; 127(1):4-5. Stahl SM. PMID: 23240592.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. Glutamate neurocircuitry: theoretical underpinnings in schizophrenia. Front Pharmacol. 2012; 3:195. Schwartz TL, Sachdeva S, Stahl SM. PMID: 23189055.
      View in: PubMed   Mentions:
    102. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment. CNS Spectr. 2012 Nov; 17 Suppl 1:10-21. Morrissette DA, Stahl SM. PMID: 23462201.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry. 2012 Nov; 73(11):1403-11. Griebel G, Beeské S, Stahl SM. PMID: 23146246.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    104. Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression. CNS Spectr. 2012 Sep; 17(3):107-20. Lum CT, Stahl SM. PMID: 23888494.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    105. Iloperidone, asenapine and lurasidone: a primer on their current status. Expert Opin Pharmacother. 2012 Sep; 13(13):1911-22. Tarazi FI, Stahl SM. PMID: 22849428.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    106. A horse of a different color: how formulation influences medication effects. CNS Spectr. 2012 Jun; 17(2):63-9. Grady MM, Stahl SM. PMID: 22789063.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    107. Antipsychotic polypharmacy: never say never, but never say always. Acta Psychiatr Scand. 2012 May; 125(5):349-51. Stahl SM. PMID: 22506490.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Practical guide for prescribing MAOIs: debunking myths and removing barriers. CNS Spectr. 2012 Mar; 17(1):2-10. Grady MM, Stahl SM. PMID: 22790112.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    109. TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception. Pharmaceuticals (Basel). 2012 Feb 02; 5(2):114-32. Brandt MR, Beyer CE, Stahl SM. PMID: 24288084.
      View in: PubMed   Mentions:
    110. Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia. Curr Pharm Des. 2012; 18(12):1580-92. Schwartz TL, Sachdeva S, Stahl SM. PMID: 22280435.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    111. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials. Hum Psychopharmacol. 2012 Jan; 27(1):24-32. Citrome L, Meng X, Hochfeld M, Stahl SM. PMID: 22161738.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    112. Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor. Ther Adv Psychopharmacol. 2011 Jun; 1(3):81-7. Schwartz TL, Siddiqui UA, Stahl SM. PMID: 23983930.
      View in: PubMed   Mentions:
    113. Treatment strategies for dosing the second generation antipsychotics. CNS Neurosci Ther. 2011 Apr; 17(2):110-7. Schwartz TL, Stahl SM. PMID: 21401911.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    114. Ziprasidone hydrocloride: what role in the management of schizophrenia? J Cent Nerv Syst Dis. 2011; 3:1-16. Mattei C, Rapagnani MP, Stahl SM. PMID: 23861634.
      View in: PubMed   Mentions:
    115. The Mechanism of Drug-induced Akathsia. CNS Spectr. 2011 Jan 15. Stahl SM, Lonnen AJ. PMID: 21406165.
      View in: PubMed   Mentions: 3     Fields:    
    116. Functional psychopharmacology is the way to go in pharmacotherapy for psychiatric disorders. Acta Psychiatr Scand. 2010 Dec; 122(6):435-7. Loonen AJ, Stahl SM. PMID: 21054280.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    117. The serotonin-7 receptor as a novel therapeutic target. J Clin Psychiatry. 2010 Nov; 71(11):1414-5. Stahl SM. PMID: 21114946.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    118. How to dose a psychotropic drug: beyond therapeutic drug monitoring to genotyping the patient. Acta Psychiatr Scand. 2010 Dec; 122(6):440-1. Stahl SM. PMID: 20880158.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    119. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med. 2011 Jan; 8(1):15-27. Stahl SM, Sommer B, Allers KA. PMID: 20840530.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    120. Illustrating the circuits of sexual desire. J Clin Psychiatry. 2010 Sep; 71(9):1113-4. Stahl SM. PMID: 20923619.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    121. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. J Clin Psychopharmacol. 2010 Aug; 30(4):425-30. Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S. PMID: 20571437.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    122. Play it Again: The Master Psychopharmacology Program as an Example of Interval Learning in Bite-Sized Portions. CNS Spectr. 2010 Aug; 15(8):491-504. Stahl SM, Davis RL, Kim DH, Lowe NG, Carlson RE, Fountain K, Grady MM. PMID: 20703196.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    123. Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder. J Clin Psychiatry. 2010 Jul; 71(7):821-2. Stahl SM. PMID: 20667289.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. Psychiatric stress testing: novel strategy for translational psychopharmacology. Neuropsychopharmacology. 2010 Jun; 35(7):1413-4. Stahl SM. PMID: 20463680.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    125. Fooling mother nature: epigenetics and novel treatments for psychiatric disorders. CNS Spectr. 2010 Jun; 15(6):358-65. Stahl SM. PMID: 20625368.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    126. Circuits of sexual desire in hypoactive sexual desire disorder. J Clin Psychiatry. 2010 May; 71(5):518-9. Stahl SM. PMID: 20492849.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    127. Methylated spirits: epigenetic hypotheses of psychiatric disorders. CNS Spectr. 2010 Apr; 15(4):220-30. Stahl SM. PMID: 20414171.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    128. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2010 Apr; 30(2):135-44. Zajecka J, Schatzberg A, Stahl S, Shah A, Caputo A, Post A. PMID: 20520286.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    129. Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial. J Clin Psychiatry. 2010 May; 71(5):616-26. Stahl SM, Fava M, Trivedi MH, Caputo A, Shah A, Post A. PMID: 20361916.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    130. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms. J Clin Psychiatry. 2010 Mar; 71(3):223-4. Stahl SM. PMID: 20331927.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    131. Enhancing outcomes from major depression: using antidepressant combination therapies with multifunctional pharmacologic mechanisms from the initiation of treatment. CNS Spectr. 2010 Feb; 15(2):79-94. Stahl SM. PMID: 20414154.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    132. Antipsychotic drug development. Curr Top Behav Neurosci. 2010; 4:123-39. Kim DH, Stahl SM. PMID: 21312399.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    133. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010 Jan; 71(1):12-3. Stahl SM. PMID: 20129003.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    134. Crisis in army psychopharmacology and mental health care at Fort Hood. CNS Spectr. 2009 Dec; 14(12):677-84. Stahl SM. PMID: 20394175.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    135. Clinical management of major depressive disorder. CNS Spectr. 2009 Nov; 14(11 Suppl 10):3-6; quiz 7-8. Mignon L, Stahl SM. PMID: 20173690.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    136. Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression. J Clin Psychiatry. 2009 Nov; 70(11):1493-4. Stahl SM. PMID: 20031093.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    137. Mechanism of action of trazodone: a multifunctional drug. CNS Spectr. 2009 Oct; 14(10):536-46. Stahl SM. PMID: 20095366.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    138. Epigenetics and methylomics in psychiatry. J Clin Psychiatry. 2009 Sep; 70(9):1204-5. Stahl SM. PMID: 19818242.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    139. Applying the principles of adult learning to the teaching of psychopharmacology: audience response systems. CNS Spectr. 2009 Aug; 14(8):412-4. Stahl SM, Davis RL. PMID: 19890234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    140. The prefrontal cortex is out of tune in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2009 Jul; 70(7):950-1. Stahl SM. PMID: 19653972.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    141. Applying the principles of adult learning to the teaching of psychopharmacology: storyboarding a presentation and the rule of small multiples. CNS Spectr. 2009 Jun; 14(6):288-94. Stahl SM, Davis RL. PMID: 19668120.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    142. Last episode psychosis. Acta Psychiatr Scand. 2009 Jun; 119(6):417-8. Munk-Jørgensen P, Nielsen J, Nielsen RE, Stahl SM. PMID: 19469724.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    143. Fibromyalgia--pathways and neurotransmitters. Hum Psychopharmacol. 2009 Jun; 24 Suppl 1:S11-7. Stahl SM. PMID: 19479906.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    144. Why psychiatrists should not ignore pain in their patients--focus on fibromyalgia? Hum Psychopharmacol. 2009 Jun; 24 Suppl 1:S1-2. Stahl SM, Briley M. PMID: 19479908.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    145. Norepinephrine and dopamine regulate signals and noise in the prefrontal cortex. J Clin Psychiatry. 2009 May; 70(5):617-8. Stahl SM. PMID: 19552863.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    146. Applying the principles of adult learning to the teaching of psychopharmacology: overview and finding the focus. CNS Spectr. 2009 Apr; 14(4):179-82. Stahl SM, Davis RL. PMID: 19407729.
      View in: PubMed   Mentions:    Fields:    
    147. Vasomotor symptoms and depression in women, part 2. Treatments that cause remission and prevent relapses of major depressive episodes overlap with treatments for vasomotor symptoms. J Clin Psychiatry. 2009 Mar; 70(3):310-1. Stahl SM. PMID: 19317957.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    148. Multifunctional drugs: a novel concept for psychopharmacology. CNS Spectr. 2009 Feb; 14(2):71-3. Stahl SM. PMID: 19238121.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    149. Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode. J Clin Psychiatry. 2009 Jan; 70(1):11-2. Stahl SM. PMID: 19222980.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    150. Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia. Neurotherapeutics. 2009 Jan; 6(1):78-85. Kim DH, Maneen MJ, Stahl SM. PMID: 19110200.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    151. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr. 2008 Dec; 13(12):1027-38. Stahl SM. PMID: 19179941.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    152. The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition? J Clin Psychiatry. 2008 Nov; 69(11):1673-4. Stahl SM. PMID: 19200426.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    153. Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants. CNS Spectr. 2008 Oct; 13(10):855-70. Stahl SM, Felker A. PMID: 18955941.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    154. L-methylfolate: a vitamin for your monoamines. J Clin Psychiatry. 2008 Sep; 69(9):1352-3. Stahl SM. PMID: 19193337.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    155. Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. CNS Spectr. 2008 Aug; 13(8):647-62. Wise DD, Felker A, Stahl SM. PMID: 18704021.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    156. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. J Clin Psychiatry. 2008 Aug; 69(8):1287-92. Papakostas GI, Stahl SM, Krishen A, Seifert CA, Tucker VL, Goodale EP, Fava M. PMID: 18605812.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    157. The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders. CNS Spectr. 2008 Jun; 13(6):467-83. Stahl SM, Wise DD. PMID: 18567971.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    158. Dosing atypical antipsychotics. CNS Spectr. 2008 May; 13(5 Suppl 9):1-16. Cutler A, Ball S, Stahl SM. PMID: 18496483.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    159. Do dopamine partial agonists have partial efficacy as antipsychotics? CNS Spectr. 2008 Apr; 13(4):279-82. Stahl SM. PMID: 18408646.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    160. Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology? CNS Spectr. 2008 Feb; 13(2):115-8. Stahl SM. PMID: 18227742.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    161. Teaching psychopharmacology: what works and what doesn't. J Clin Psychopharmacol. 2008 Feb; 28(1):96-100. Zisook S, Glick ID, Jefferson JW, Wagner KD, Salzman C, Peselow ED, Stahl S. PMID: 18204350.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    162. Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder. Curr Med Res Opin. 2007 Nov; 23(11):2815-22. Rupnow MF, Greenspan A, Gharabawi GM, Kosik-Gonzalez C, Zhu Y, Stahl SM. PMID: 17910802.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    163. Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr. 2007 Oct; 12(10):739-44. Stahl SM. PMID: 17934378.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    164. Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER. CNS Spectr. 2007 Sep; 12(9):703-11. Stahl SM, Ahmed S, Haudiquet V. PMID: 17805217.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    165. Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism. Int J Neuropsychopharmacol. 2007 Oct; 10(5):575-8. Stahl SM. PMID: 17681087.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    166. The genetics of schizophrenia converge upon the NMDA glutamate receptor. CNS Spectr. 2007 Aug; 12(8):583-8. Stahl SM. PMID: 17667886.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    167. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci. 2007 Jul; 28(7):316-25. Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE. PMID: 17573127.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansAnimals
    168. Novel therapeutics for schizophrenia: targeting glycine modulation of NMDA glutamate receptors. CNS Spectr. 2007 Jun; 12(6):423-7. Stahl SM. PMID: 17545952.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    169. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology. 2008 Feb; 33(3):574-87. Stemmelin J, Cohen C, Terranova JP, Lopez-Grancha M, Pichat P, Bergis O, Decobert M, Santucci V, Françon D, Alonso R, Stahl SM, Keane P, Avenet P, Scatton B, le Fur G, Griebel G. PMID: 17460614.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    170. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. CNS Spectr. 2007 Apr; 12(4):265-8. Stahl SM. PMID: 17426663.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    171. Overview of trends in modern psychopharmacology. CNS Spectr. 2007 Feb; 12(2):103-5. Stahl SM. PMID: 17277709.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    172. Positive findings for negative symptoms of schizophrenia: no longer untreatable? Acta Psychiatr Scand. 2006 Nov; 114(5):301-2. Stahl SM. PMID: 17022789.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    173. Temperature regulation in depression: functional 5HT1A receptor adaptation differentiates antidepressant response. Neuropsychopharmacology. 2006 Oct; 31(10):2274-80. Rausch JL, Johnson ME, Kasik KE, Stahl SM. PMID: 16641936.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    174. High-cost use of second-generation antipsychotics under California's Medicaid program. Psychiatr Serv. 2006 Jan; 57(1):127-9. Stahl SM, Grady MM. PMID: 16399974.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    175. Finding what you are not looking for: strategies for developing novel treatments in psychiatry. NeuroRx. 2006 Jan; 3(1):3-9. Stahl SM. PMID: 16490409.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    176. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr. 2005 Sep; 10(9):732-47. Stahl SM, Grady MM, Moret C, Briley M. PMID: 16142213.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    177. Emotion processing, the amygdala, and outcome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):840-5. Shayegan DK, Stahl SM. PMID: 15925435.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    178. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor. CNS Spectr. 2005 Apr; 10(4):319-23. Stahl SM. PMID: 15788959.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    179. Is psychopharmacologic "inoculation" effective in preventing posttraumatic stress disorder? J Clin Psychiatry. 2005 Jan; 66(1):5-6. Stahl SM. PMID: 15669882.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    180. Toward convergence in the medication treatment of bipolar disorder and schizophrenia. Harv Rev Psychiatry. 2005 Jan-Feb; 13(1):28-42. Citrome L, Goldberg JF, Stahl SM. PMID: 15804932.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    181. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry. 2005; 7(3):106-13. Fava M, Rush AJ, Thase ME, Clayton A, Stahl SM, Pradko JF, Johnston JA. PMID: 16027765.
      View in: PubMed   Mentions:
    182. Preemptive analgesia: is pain less costly when you pre-pay for it? J Clin Psychiatry. 2004 Dec; 65(12):1591-2. Stahl SM. PMID: 15641861.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    183. Risperidone and paroxetine given singly and in combination for bipolar depression. J Clin Psychiatry. 2004 Dec; 65(12):1715-9. Shelton RC, Stahl SM. PMID: 15641878.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    184. Prophylactic antipsychotics: do they keep you from catching schizophrenia? J Clin Psychiatry. 2004 Nov; 65(11):1445-6. Stahl SM. PMID: 15554754.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    185. The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol. 2005 Mar; 8(1):93-105. Demyttenaere K, De Fruyt J, Stahl SM. PMID: 15482632.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    186. A successful antipsychotic combination trial. Quo Vadis? Acta Psychiatr Scand. 2004 Oct; 110(4):241-2. Stahl S, Freudenreich O, Goff D. PMID: 15352924.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    187. Understanding pain in depression. Hum Psychopharmacol. 2004 Oct; 19 Suppl 1:S9-S13. Stahl S, Briley M. PMID: 15378669.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    188. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. CNS Spectr. 2004 Oct; 9(10 Suppl 11):6-14. Shayegan DK, Stahl SM. PMID: 15475871.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    189. Drug combinations for bipolar spectrum disorders: evidence-based prescribing or prescribing-based evidence? J Clin Psychiatry. 2004 Oct; 65(10):1298-9. Stahl SM. PMID: 15491230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    190. Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator. J Clin Psychiatry. 2004 Sep; 65(9):1162-3. Stahl SM. PMID: 15367040.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    191. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. J Clin Psychiatry. 2004 Aug; 65(8):1114-9. Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins HS. PMID: 15323598.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCTClinical Trials
    192. Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators. J Clin Psychiatry. 2004 Aug; 65(8):1033-4. Stahl SM. PMID: 15323585.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    193. Mechanism of action of voltage sensitive sodium channel modulators. J Clin Psychiatry. 2004 Jul; 65(7):894-5. Stahl SM. PMID: 15291674.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    194. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels. J Clin Psychiatry. 2004 Jun; 65(6):738-9. Stahl SM. PMID: 15291647.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    195. Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels. J Clin Psychiatry. 2004 May; 65(5):596-7. Stahl SM. PMID: 15163243.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    196. Anticonvulsants as anxiolytics, part 2: Pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels. J Clin Psychiatry. 2004 Apr; 65(4):460-1. Stahl SM. PMID: 15119905.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    197. Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease. Curr Med Res Opin. 2004 Apr; 20(4):517-24. Stahl SM, Markowitz JS, Papadopoulos G, Sadik K. PMID: 15119989.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    198. Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA. J Clin Psychiatry. 2004 Mar; 65(3):291-2. Stahl SM. PMID: 15096065.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    199. Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence? Int J Neuropsychopharmacol. 2004 Jun; 7(2):113-6. Stahl SM. PMID: 14984629.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    200. Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action? J Clin Psychiatry. 2004 Feb; 65(2):149-50. Stahl SM. PMID: 15003065.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    201. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. Prim Care Companion J Clin Psychiatry. 2004; 6(4):159-166. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. PMID: 15361919.
      View in: PubMed   Mentions:
    202. Symptoms and circuits, part 3: schizophrenia. J Clin Psychiatry. 2004 Jan; 65(1):8-9. Stahl SM. PMID: 14744162.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    203. Selectivity of SSRIs: individualising patient care through rational treatment choices. Int J Psychiatry Clin Pract. 2004; 8 Suppl 1:3-10. Stahl SM. PMID: 24930682.
      View in: PubMed   Mentions: 1     Fields:    
    204. Brainstorms: symptoms and circuits, part 2: anxiety disorders. J Clin Psychiatry. 2003 Dec; 64(12):1408-9. Stahl SM. PMID: 14728099.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    205. Symptoms and circuits, part 1: major depressive disorder. J Clin Psychiatry. 2003 Nov; 64(11):1282-3. Stahl SM. PMID: 14658940.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    206. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2003 Nov; 64(11):1322-7. Stahl SM, Gergel I, Li D. PMID: 14658946.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    207. Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist. J Clin Psychiatry. 2003 Oct; 64(10):1145-6. Stahl SM. PMID: 14658960.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    208. Deconstructing psychiatric disorders, Part 1. Genotypes, symptom phenotypes, and endophenotypes. J Clin Psychiatry. 2003 Sep; 64(9):982-3. Stahl SM. PMID: 14628971.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    209. Here today and not gone tomorrow: the curse of chronic pain and other central sensitization syndromes. J Clin Psychiatry. 2003 Aug; 64(8):863-4. Stahl SM. PMID: 12926998.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    210. Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes. J Clin Psychiatry. 2003 Jul; 64(7):745-6. Stahl SM. PMID: 12934972.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    211. The ups and downs of novel antiemetic drugs, part 2: an illustration. J Clin Psychiatry. 2003 Jun; 64(6):626-7. Stahl SM. PMID: 12823074.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    212. The ups and downs of novel antiemetic drugs, part 1: substance P, 5-HT, and the neuropharmacology of vomiting. J Clin Psychiatry. 2003 May; 64(5):498-9. Stahl SM. PMID: 12755650.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    213. At long last, long-lasting psychiatric medications: an overview of controlled-release technologies. J Clin Psychiatry. 2003 Apr; 64(4):355-6. Stahl SM. PMID: 12716234.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    214. Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community. J Clin Psychiatry. 2003 Apr; 64(4):466-72. Stahl SM, Markowitz JS, Gutterman EM, Papadopoulos G. PMID: 12716251.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    215. Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex. J Clin Psychiatry. 2003 Mar; 64(3):230-1. Stahl SM. PMID: 12716261.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    216. Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition. J Clin Psychiatry. 2003 Feb; 64(2):110-1. Stahl SM. PMID: 12633117.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    217. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. J Clin Psychiatry. 2003; 64 Suppl 19:6-12. Stahl SM, Shayegan DK. PMID: 14728084.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    218. A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J Biol Psychiatry. 2003 Jan; 4(1):30-4. Hollander E, Kaplan A, Stahl SM. PMID: 12582975.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    219. Neurotransmission of cognition, part 1, Dopamine is a hitchhiker in frontal cortex: norepinephrine transporters regulate dopamine. J Clin Psychiatry. 2003 Jan; 64(1):4-5. Stahl SM. PMID: 12590617.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    220. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry. 2003; 64 Suppl 13:13-7. Stahl SM, Grady MM. PMID: 14552651.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    221. Introduction: optimizing wakefulness in patients with fatigue and executive dysfunction. J Clin Psychiatry. 2003; 64 Suppl 14:3-4. Stahl SM. PMID: 14658928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    222. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J Clin Psychiatry. 2003; 64 Suppl 14:6-17. Stahl SM, Zhang L, Damatarca C, Grady M. PMID: 14658930.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    223. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry. 2002 Dec 15; 52(12):1166-74. Stahl SM, Entsuah R, Rudolph RL. PMID: 12488062.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    224. The metabolic syndrome: psychopharmacologists should weigh the evidence for weighing the patient. J Clin Psychiatry. 2002 Dec; 63(12):1094-5. Stahl SM. PMID: 12523866.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    225. Some relationships among assessments of depression. J Clin Psychol. 2002 Dec; 58(12):1545-53. Lutz W, Stahl SM, Howard KI, Grissom GR, Joske R. PMID: 12455021.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    226. Can psychopharmacologic treatments that relieve symptoms also prevent disease progression? J Clin Psychiatry. 2002 Nov; 63(11):961-2. Stahl SM. PMID: 12444807.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    227. Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents. J Clin Psychiatry. 2002 Oct; 63(10):854-5. Stahl SM. PMID: 12416593.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    228. Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. J Clin Psychiatry. 2002 Sep; 63(9):756-7. Stahl SM. PMID: 12363113.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    229. Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials. J Clin Psychopharmacol. 2002 Aug; 22(4):388-92. Stahl SM, Mendels J, Schwartz GE. PMID: 12172338.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    230. Mirror, mirror on the wall, which enantiomer is fairest of them all? J Clin Psychiatry. 2002 Aug; 63(8):656-7. Stahl SM. PMID: 12197444.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    231. Psychopharmacology of wakefulness: pathways and neurotransmitters. J Clin Psychiatry. 2002 Jul; 63(7):551-2. Stahl SM. PMID: 12143908.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    232. Awakening to the psychopharmacology of sleep and arousal: novel neurotransmitters and wake-promoting drugs. J Clin Psychiatry. 2002 Jun; 63(6):467-8. Stahl SM. PMID: 12088156.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    233. The psychopharmacology of painful physical symptoms in depression. J Clin Psychiatry. 2002 May; 63(5):382-3. Stahl SM. PMID: 12019660.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    234. Does depression hurt? J Clin Psychiatry. 2002 Apr; 63(4):273-4. Stahl SM. PMID: 12000200.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    235. Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes. J Clin Psychiatry. 2002 Mar; 63(3):179-80. Stahl SM. PMID: 11926714.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    236. Antipsychotic polypharmacy: squandering precious resources? J Clin Psychiatry. 2002 Feb; 63(2):93-4. Stahl SM. PMID: 11874226.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    237. The psychopharmacology of energy and fatigue. J Clin Psychiatry. 2002 Jan; 63(1):7-8. Stahl SM. PMID: 11838630.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    238. Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants. Int J Neuropsychopharmacol. 1998 Jul; 1(1):11-18. Stahl SM, Kaiser L, Roeschen J, Keppel Hesselink JM, Orazem J. PMID: 11281940.
      View in: PubMed   Mentions: 4     Fields:    
    239. The International Journal of Neuropsychopharmacology. Int J Neuropsychopharmacol. 1998 Jul; 1(1):1-2. Lerer B, Frazer A, Stahl S, Farde L, Lesch P. PMID: 11343572.
      View in: PubMed   Mentions:    Fields:    
    Stephen's Networks
    Concepts (568)
    Derived automatically from this person's publications.
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _